|

CD19 CAR T-cell Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Beijing GoBroad Hospital1

Indications

  • Refractory Acute Lymphoid Leukemia1
  • Acute Lymphoblastic Leukemia, in Relapse1
  • B-cell Acute Lymphoblastic Leukemia1
  • Cancer1

Other1 trial

Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.